LONG-TERM SPARSENTAN TREATMENT IN YOUNG PATIENTS WITH FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)

Category Primary study
JournalAmerican Journal of Kidney Diseases
Year 2023
This article has no abstract
Epistemonikos ID: aa22d4ad5e4900260155c284f89c68813833f625
First added on: Feb 16, 2025